These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29174780)

  • 1. Hospitalization Costs After Surgery in High-Risk Patients With Early Stage Lung Cancer.
    Sancheti MS; Chihara RK; Perez SD; Khullar OV; Fernandez FG; Pickens A; Force SD
    Ann Thorac Surg; 2018 Jan; 105(1):263-270. PubMed ID: 29174780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes After Surgery in High-Risk Patients With Early Stage Lung Cancer.
    Sancheti MS; Melvan JN; Medbery RL; Fernandez FG; Gillespie TW; Li Q; Binongo JN; Pickens A; Force SD
    Ann Thorac Surg; 2016 Mar; 101(3):1043-50; Discussion 1051. PubMed ID: 26572255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.
    Gulack BC; Yang CJ; Speicher PJ; Yerokun BA; Tong BC; Onaitis MW; D'Amico TA; Harpole DH; Hartwig MG; Berry MF
    Ann Thorac Surg; 2016 Dec; 102(6):1814-1820. PubMed ID: 27592602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
    Kwan SW; Mortell KE; Hippe DS; Brunner MC
    J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance).
    Kent MS; Mandrekar SJ; Landreneau R; Nichols F; DiPetrillo TA; Meyers B; Heron DE; Jones DR; Tan AD; Starnes S; Putnam JB; Fernando HC
    Ann Thorac Surg; 2016 Jul; 102(1):230-8. PubMed ID: 27101728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron DE; Jones DR; Daly BD; Starnes SL; Tan A; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1143-51. PubMed ID: 21872277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy.
    Lee PC; Kamel M; Nasar A; Ghaly G; Port JL; Paul S; Stiles BM; Andrews WG; Altorki NK
    Ann Thorac Surg; 2016 Mar; 101(3):1116-22. PubMed ID: 26654728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron D; Jones DR; Daly BD; Starnes SL; Hatter JE; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):554-62. PubMed ID: 21724195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients.
    Kent M; Landreneau R; Mandrekar S; Hillman S; Nichols F; Jones D; Starnes S; Tan A; Putnam J; Meyers B; Daly B; Fernando HC
    Ann Thorac Surg; 2013 Nov; 96(5):1747-54; discussion 1754-5. PubMed ID: 23998400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomic thoracoscopic lung resection for non-small cell lung cancer in stage I is associated with less morbidity and shorter hospitalization than thoracotomy.
    Ilonen IK; Räsänen JV; Knuuttila A; Salo JA; Sihvo EI
    Acta Oncol; 2011 Oct; 50(7):1126-32. PubMed ID: 21314296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults.
    Smith BD; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Shirvani SM
    J Geriatr Oncol; 2015 Jul; 6(4):324-31. PubMed ID: 26094172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer.
    Landreneau RJ; Sugarbaker DJ; Mack MJ; Hazelrigg SR; Luketich JD; Fetterman L; Liptay MJ; Bartley S; Boley TM; Keenan RJ; Ferson PF; Weyant RJ; Naunheim KS
    J Thorac Cardiovasc Surg; 1997 Apr; 113(4):691-8; discussion 698-700. PubMed ID: 9104978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
    Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more?
    Alexander ES; Machan JT; Ng T; Breen LD; DiPetrillo TA; Dupuy DE
    J Vasc Interv Radiol; 2013 Apr; 24(4):476-82. PubMed ID: 23462066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Surgeon Volume on Outcomes of Older Stage I Lung Cancer Patients Treated via Video-assisted Thoracoscopic Surgery.
    Smith CB; Wolf A; Mhango G; Wisnivesky JP
    Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):223-230. PubMed ID: 28823334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
    Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
    Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer.
    Okami J; Ito Y; Higashiyama M; Nakayama T; Tokunaga T; Maeda J; Kodama K
    Ann Thorac Surg; 2010 Nov; 90(5):1651-6. PubMed ID: 20971281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.